Rapamycin Eluting Coronary Stent Implantation System
- UID
- MFG/MD/2019/000029_2fc8f238c5ed238ad91f96c02e8be3a2_0e856482c5ad05b85df8d0d71f051491
- Device class
- Class D
- Brand name
- 3V SIRIS
- License holder
- S3V Vascular Technologies Pvt Ltd
- Approving authority
- Sub Zonal Bangalore
- Product information
- Indicated for improving coronary luminal diameter in patients with symptomatic ischemic disease due to discrete de novo and in-stent restenotic lesions in native coronary arteries
Rapamycin Eluting Coronary Stent Implantation System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2019/000029_2fc8f238c5ed238ad91f96c02e8be3a2_0e856482c5ad05b85df8d0d71f051491. This device is marketed under the brand name 3V SIRIS. The license holder is S3V Vascular Technologies Pvt Ltd, and it is classified as Device Class Class D. The approving authority is Sub Zonal Bangalore.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.